Exact Mass: 620.3057284

Exact Mass Matches: 620.3057284

Found 58 metabolites which its exact mass value is equals to given mass value 620.3057284, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0)

[(2R)-2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C29H49O12P (620.2961484)

LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0), in particular, consists of one chain of arachidonic acid at the C-1 position.

PI(20:4(5Z,8Z,11Z,14Z)/0:0)

[2-hydroxy-3-(icosa-5,8,11,14-tetraenoyloxy)propoxy][(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid

C29H49O12P (620.2961484)

Lotusanine B

Lotusanine B

C37H40N4O5 (620.299855)

Phosphatidylinositol lyso 20:4

Phosphatidylinositol lyso 20:4

C29H49O12P (620.2961484)

dichrostachine F

dichrostachine F

C36H44O9 (620.2985174)

3,28-Disulfate-Cycloartane-3,23,28-triol

3,28-Disulfate-Cycloartane-3,23,28-triol

C30H52O9S2 (620.3052582)

nimbolinin D

nimbolinin D

C36H44O9 (620.2985174)

(+)-cryptophycin B|(7R,8R)-Epoxide-Cryptophycin D|cryptophycin 52|cryptophycin B|cryptophycin-2

(+)-cryptophycin B|(7R*,8R*)-Epoxide-Cryptophycin D|cryptophycin 52|cryptophycin B|cryptophycin-2

C35H44N2O8 (620.3097504)

Pro Arg Trp Tyr

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Pro Arg Tyr Trp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Pro Trp Arg Tyr

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Pro Trp Tyr Arg

(2S)-5-carbamimidamido-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanoic acid

C31H40N8O6 (620.3070660000001)

Pro Tyr Arg Trp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Pro Tyr Trp Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-(1H-indol-3-yl)propanamido]pentanoic acid

C31H40N8O6 (620.3070660000001)

Arg Pro Trp Tyr

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Arg Pro Tyr Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Arg Trp Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Arg Trp Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

Arg Tyr Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Arg Tyr Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

Trp Pro Arg Tyr

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Trp Pro Tyr Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C31H40N8O6 (620.3070660000001)

Trp Arg Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C31H40N8O6 (620.3070660000001)

Trp Arg Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

Trp Tyr Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C31H40N8O6 (620.3070660000001)

Trp Tyr Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

Tyr Pro Arg Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Tyr Pro Trp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C31H40N8O6 (620.3070660000001)

Tyr Arg Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C31H40N8O6 (620.3070660000001)

Tyr Arg Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

Tyr Trp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C31H40N8O6 (620.3070660000001)

Tyr Trp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C31H40N8O6 (620.3070660000001)

20:4 Lyso-PI

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

C29H49O12P (620.2961484)

LPI 20:4

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

C29H49O12P (620.2961484)

(2S)-2-[[(2S)-2-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-3,4-dihydro-1H-isoquinolin-3-yl]methylamino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-3,4-dihydro-1H-isoquinolin-3-yl]methylamino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid

C37H40N4O5 (620.299855)

3-[2,3-bis(3-hydroxypropoxy)propoxy]propan-1-ol,1,3-diisocyanato-2-methylbenzene,2,4-diisocyanato-1-methylcyclohexane

3-[2,3-bis(3-hydroxypropoxy)propoxy]propan-1-ol,1,3-diisocyanato-2-methylbenzene,2,4-diisocyanato-1-methylcyclohexane

C30H44N4O10 (620.3057284)

6-Hydroxyparomomycin

6-Hydroxyparomomycin

C23H48N4O15+4 (620.3116018)

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

C29H49O12P (620.2961484)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

C29H49O12P (620.2961484)

PI(0:0/20:4(5Z,8Z,11Z,14Z))

PI(0:0/20:4(5Z,8Z,11Z,14Z))

C29H49O12P (620.2961484)

(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-N-[3-(4-morpholinyl)propyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-N-[3-(4-morpholinyl)propyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H44N4O5S (620.3032254)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C29H49O12P (620.2961484)

1-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol

1-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol

C29H49O12P (620.2961484)

A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as arachidonoyl.

DGMG 14:3

DGMG 14:3

C29H48O14 (620.3043908)

PA 22:5/8:3;O

PA 22:5/8:3;O

C33H49O9P (620.3114034)

PA 30:8;O

PA 30:8;O

C33H49O9P (620.3114034)

LPGP 20:0

LPGP 20:0

C26H54O12P2 (620.3090344000001)

PG O-23:5;O3

PG O-23:5;O3

C29H49O12P (620.2961484)

PG P-16:1/7:3;O3

PG P-16:1/7:3;O3

C29H49O12P (620.2961484)

PG 14:0/9:4;O2

PG 14:0/9:4;O2

C29H49O12P (620.2961484)

PG 16:1/7:3;O2

PG 16:1/7:3;O2

C29H49O12P (620.2961484)

PG 18:3/5:1;O2

PG 18:3/5:1;O2

C29H49O12P (620.2961484)

PG 23:4;O2

PG 23:4;O2

C29H49O12P (620.2961484)

LPI 0:0/20:4

LPI 0:0/20:4

C29H49O12P (620.2961484)

LPI 20:4/0:0

LPI 20:4/0:0

C29H49O12P (620.2961484)

PEth 28:8;O

PEth 28:8;O

C33H49O9P (620.3114034)

PM 29:8;O

PM 29:8;O

C33H49O9P (620.3114034)

ST 23:0;O8;GlcA

ST 23:0;O8;GlcA

C29H48O14 (620.3043908)